CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17190951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared the responsiveness of the Cervical Dystonia Impact Profile (CDIP-58), Medical Outcome Study Short Form-Health Survey (SF-36), Functional Disability Questionnaire (FDQ), and Pain and Activities of Daily Living subscales of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in participants with cervical dystonia treated with botulinum toxin A. Subscales of CDIP-58 were more sensitive in detecting statistical and clinical change than comparable subscales of the SF-36, FDQ, and TWSTRS.
Medical subject headings
- Botulinum Toxins, Type A
- Neck Pain
- Outcome Assessment, Health Care
- Sickness Impact Profile
- Torticollis